PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058460
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058460
Orthopedic Splints And Casts Market is estimated to be valued at USD 3.68 Bn in 2026 and is expected to reach USD 5.65 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.68 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.40% | 2033 Value Projection: | USD 5.65 Bn |
Orthopedic splints and casts are majorly available in fiberglass and plastic materials, which are applied over the injured area after being dipped in water. Fiberglass cast and splint products provide high patient compliance in terms of wearing comfort, water resistance and lasting support, improved X-ray radiolucency, and minimized muscle atrophy and other immobilization-related issues, thus, increasing the adoption of these products. Moreover, splints and casts are widely used to manage trauma and fall injuries, as they promote healing, help maintain bone alignment, and protect the injury.
Major factors driving growth of the orthopedic splints and casts market include increasing number of age-related orthopedic disorders and improved healthcare facilities in emerging economies. Furthermore, wide adoption of orthopedic splints and casts with increasing surgical procedures and trauma cases is expected to fuel the market growth over the forecast period. According to the study by Orthoknow, 2012, around 2.9 million joint replacement procedures occur annually worldwide, including over 1.4 million hip procedures, 1.1 million knee procedures, and around 100,000 shoulder replacements. Also, according to the Centers for Disease Control and Prevention, 2016, around 1.6 million hip fractures occur each year globally, the number of which is expected to reach between 4.5 million and 6.3 million by 2050.
However, complications associated with casts and splints such as deep vein thrombosis, allergic reactions, neurovascular deficit, in turn, are expected to limit the adoption of these products, further hindering the orthopedic splints and casts market growth.